XORTX Therapeutics (NASDAQ:XRTX – Get Free Report) announced its earnings results on Saturday. The technology company reported ($1.05) EPS for the quarter, FiscalAI reports.
XORTX Therapeutics Trading Down 0.9%
NASDAQ XRTX traded down $0.02 during mid-day trading on Friday, hitting $2.17. The company’s stock had a trading volume of 4,964 shares, compared to its average volume of 12,542. The firm has a market capitalization of $3.94 million, a price-to-earnings ratio of -0.83 and a beta of 0.73. The company’s 50 day simple moving average is $2.11 and its 200 day simple moving average is $2.23. XORTX Therapeutics has a twelve month low of $1.73 and a twelve month high of $7.05.
Institutional Inflows and Outflows
An institutional investor recently raised its position in XORTX Therapeutics stock. Citadel Advisors LLC lifted its holdings in shares of XORTX Therapeutics Inc. (NASDAQ:XRTX – Free Report) by 124.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 86,326 shares of the technology company’s stock after acquiring an additional 47,858 shares during the period. Citadel Advisors LLC owned approximately 1.24% of XORTX Therapeutics worth $70,000 at the end of the most recent reporting period. 0.23% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
Read Our Latest Stock Analysis on XORTX Therapeutics
XORTX Therapeutics Company Profile
Xyratex Ltd (Xyratex) is a provider of data storage technology, including modular solutions for the enterprise data storage industry and hard disk drive (HDD) capital equipment for the HDD industry. Xyratex operates in two segments: Networked Storage Solutions (NSS) and Storage Infrastructure (SI). Its NSS products are primarily HDD based data storage subsystems and solutions, which it provides to original equipment manufacturers. Its SI products consist of HDD manufacturing process equipment, which it sells directly to manufacturers of HDDs and their component suppliers.
Featured Stories
- Five stocks we like better than XORTX Therapeutics
- Is Best Buy the AI Winner Hiding in the Electronics Aisle?
- Applied Materials Beat Everything but Wall Street’s Expectations for Margins
- Back From Orbit, Intuitive Machines’ Share Price Enters the Buy Zone
- Texas Roadhouse and Brinker International Have the Recipe Rivals Are Missing
Receive News & Ratings for XORTX Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XORTX Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
